Our finding of a strong inverse association between FGF21 and NAFLD severity is supported by two recent experimental studies showing that tumor necrosis factor and oxidative stress-activated transcription factors, such as NFE2-related factor 2, may impair FGF21 transcription and release [32], [33]. This evidence concerns the gene TNF and metabolic dysfunction-associated steatotic liver disease.